New Tool Helps Researchers Identify Flawed Clinical Trials Before They Mislead Evidence

Researchers have developed a new tool to detect problematic clinical trials—including those affected by human error or research misconduct—before they distort systematic reviews and influence treatment guidelines. Flawed studies can lead to inaccurate or harmful medical recommendations. A notable example occurred with ivermectin for COVID-19 treatment, where some trials used in systematic reviews were found to be inauthentic by U.S., U.K., and EU health authorities. Subsequent high-quality trials showed ivermectin provided little or no benefit. This new screening tool aims to strengthen the integrity of medical evidence and protect patients from potentially ineffective treatments.